Leonard Bergau
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Leonard Bergau has a total of 260 co-authors. Here are the top co-authors by number of shared publications:
- Philipp Sommer
Clinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-University Bochum , Bad Oeynhausen
13 shared publications - Christian Sohns
Department of Electrophysiology, Heart and Diabetes Center NRW, Ruhr University Bochum, Bad Oeynhausen, Germany
12 shared publications - Thomas Fink
Department of Electrophysiology, Heart- and Diabetescenter NRW, Ruhr-University Bochum , Bad Oeynhausen
11 shared publications - Denise Guckel
Clinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum , Bad Oeynhausen
10 shared publications - Guram Imnadze
Clinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Bad Oeynhausen, Germany
10 shared publications - Vanessa Sciacca
Ruhr-Universität Bochum
10 shared publications
Latest Publications
- Open Access
- 20 June 2026
- Published by Wiley in Pacing and Clinical Electrophysiology
First Experience With Extravascular Implantable Cardioverter‐Defibrillator Under Deep Sedation
Background: The Extravascular Implantable Cardioverter‐Defibrillator (EV‐ICD) utilizes a substernal lead to provide defibrillation and anti‐tachycardia pacing (ATP) while avoiding transvenous complications. General anesthesia (GA) was applied for implantation procedures in the EV‐ICD pivotal trial and is currently recommended by the manufacturer. However, GA carries specific risks and consumes significant resources. This study evaluates the feasibility, safety, and procedural efficiency of EV‐ICD implantation performed under cardiologist‐administered deep sedation with noninvasive ventilation (DS‐NIV) compared to standard GA. Methods: We retrospectively analyzed 24 consecutive patients undergoing EV‐ICD implantation in our center. Patients received either GA ( n = 14) or DS‐NIV ( n = 10) using a propofol‐ketamine protocol delivered by cardiologists. Analyses focused on peri‐procedural feasibility and safety, procedural workflow and anesthesia characteristics, and early device electrical performance. Results: No anesthesia‐related complications occurred in either group. The DS‐NIV group demonstrated significantly shorter wheels‐to‐incision times (median: 45 vs. 70 min, p = 0.022), whereas the procedural duration did not differ significantly from the GA group. Patients receiving DS‐NIV required fewer vasopressors (60% vs. 100%, p = 0.024) despite higher propofol infusion rates (800 vs. 350 mg/h, P <0.001). Defibrillation testing success and electrical parameters were comparable. In a median follow‐up of 182 days two patients received appropriate EV‐ICD therapies and no inappropriate ATP or shocks were delivered. Conclusion: EV‐ICD implantation under cardiologist‐administered DS‐NIV appears to be feasible and safe, offering improved workflow efficiency compared to GA. These findings support deep sedation as a practical alternative in experienced centers, potentially expanding access to EV‐ICD therapy.
- 20 June 2026
- Published by Wiley in Pacing and Clinical Electrophysiology
Open AccessFirst Experience With Extravascular Implantable Cardioverter‐Defibrillator Under Deep Sedation
Background: The Extravascular Implantable Cardioverter‐Defibrillator (EV‐ICD) utilizes a substernal lead to provide defibrillation and anti‐tachycardia pacing (ATP) while avoiding transvenous complications. General anesthesia (GA) was applied for implantation procedures in the EV‐ICD pivotal trial and is currently recommended by the manufacturer. However, GA carries specific risks and consumes significant resources. This study evaluates the feasibility, safety, and procedural efficiency of EV‐ICD implantation performed under cardiologist‐administered deep sedation with noninvasive ventilation (DS‐NIV) compared to standard GA. Methods: We retrospectively analyzed 24 consecutive patients undergoing EV‐ICD implantation in our center. Patients received either GA ( n = 14) or DS‐NIV ( n = 10) using a propofol‐ketamine protocol delivered by cardiologists. Analyses focused on peri‐procedural feasibility and safety, procedural workflow and anesthesia characteristics, and early device electrical performance. Results: No anesthesia‐related complications occurred in either group. The DS‐NIV group demonstrated significantly shorter wheels‐to‐incision times (median: 45 vs. 70 min, p = 0.022), whereas the procedural duration did not differ significantly from the GA group. Patients receiving DS‐NIV required fewer vasopressors (60% vs. 100%, p = 0.024) despite higher propofol infusion rates (800 vs. 350 mg/h, P <0.001). Defibrillation testing success and electrical parameters were comparable. In a median follow‐up of 182 days two patients received appropriate EV‐ICD therapies and no inappropriate ATP or shocks were delivered. Conclusion: EV‐ICD implantation under cardiologist‐administered DS‐NIV appears to be feasible and safe, offering improved workflow efficiency compared to GA. These findings support deep sedation as a practical alternative in experienced centers, potentially expanding access to EV‐ICD therapy.
- Open Access
- 3 June 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28 (1) , e86692
Performance of Vision-Enabled Large Language Models in Image-Based Electrocardiogram Interpretation: Exploratory Evaluation
Background: Vision-enabled large language models (VE-LLMs) have the potential to provide flexible and explainable medical image interpretation. However, their real-world performance on clinical data, such as 12-lead electrocardiograms (ECGs), has not been systematically assessed. Objective: This study aimed to evaluate the diagnostic accuracy and reliability of state-of-the-art generalist VE-LLMs in interpreting real-world ECG images. Methods: We tested 6 generalist VE-LLMs (ChatGPT-5, ChatGPT-4, Gemini 2.5, Copilot, Claude Sonnet-4, and Claude Opus-4.1) using 70 deidentified ECG images. A standardized prompt requested 9 determinations: rhythm, first-degree atrioventricular (AV) block, intraventricular conduction block and pattern, corrected QT (QTc) prolongation, premature atrial and ventricular contractions, ischemic ST-segment deviation, and axis deviation. An expert consensus served as the reference standard. Moreover, 2 image-based ECG-specialized LLMs (PULSE-7B and ECG-Instruct-Llama-3.2-11B-Vision) were tested for exploratory comparison. Model outputs were evaluated using overall and per-category diagnostic metrics. Results: Overall balanced accuracy across generalist models ranged from 50.1% to 61.8% (Cochran Q, P <.001). ChatGPT-5 achieved the highest balanced accuracy (61.8%) but had the slowest response time (median 276, IQR 110-407 s), whereas Copilot responded within a median of 3 (IQR 2-4) seconds. Balanced accuracy for rhythm classification ranged from 38.6% to 55.8%, but sensitivity for atrial fibrillation among generalist models was ≤11.1%, detecting either none or only 1 of the 9 cases. Detection of first-degree AV block (sensitivity 0%‐22%; 0/9 to 2/9) and QTc prolongation (sensitivity 0%‐45.5%; 0/22 to 10/22) was poor. Intraventricular block was identified with up to 67.8% balanced accuracy, but correct subtype assignment was ≤44% (≤11/25). ST-segment deviation sensitivity was <25% for all generalist models (highest 3/14). Agreement with expert interpretation was low, with Cohen κ indicating poor-to-fair concordance (κ≤0.39). Specialized models achieved overall balanced accuracy of 56.5% (ECG-Instruct-Llama-3.2-11B-Vision) and 64.4% (PULSE-7B), with PULSE-7B showing higher task-specific balanced accuracy in rhythm classification and ectopic beats detection (up to 86.3% and 89.2%, respectively). Conclusions: VE-LLMs showed moderate overall performance but mostly low sensitivity and limited agreement with expert ECG interpretation. Current performance remains inconsistent across models and diagnostic categories and is insufficient to support clinical deployment.
- 3 June 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28 (1) , e86692
Open AccessPerformance of Vision-Enabled Large Language Models in Image-Based Electrocardiogram Interpretation: Exploratory Evaluation
Background: Vision-enabled large language models (VE-LLMs) have the potential to provide flexible and explainable medical image interpretation. However, their real-world performance on clinical data, such as 12-lead electrocardiograms (ECGs), has not been systematically assessed. Objective: This study aimed to evaluate the diagnostic accuracy and reliability of state-of-the-art generalist VE-LLMs in interpreting real-world ECG images. Methods: We tested 6 generalist VE-LLMs (ChatGPT-5, ChatGPT-4, Gemini 2.5, Copilot, Claude Sonnet-4, and Claude Opus-4.1) using 70 deidentified ECG images. A standardized prompt requested 9 determinations: rhythm, first-degree atrioventricular (AV) block, intraventricular conduction block and pattern, corrected QT (QTc) prolongation, premature atrial and ventricular contractions, ischemic ST-segment deviation, and axis deviation. An expert consensus served as the reference standard. Moreover, 2 image-based ECG-specialized LLMs (PULSE-7B and ECG-Instruct-Llama-3.2-11B-Vision) were tested for exploratory comparison. Model outputs were evaluated using overall and per-category diagnostic metrics. Results: Overall balanced accuracy across generalist models ranged from 50.1% to 61.8% (Cochran Q, P <.001). ChatGPT-5 achieved the highest balanced accuracy (61.8%) but had the slowest response time (median 276, IQR 110-407 s), whereas Copilot responded within a median of 3 (IQR 2-4) seconds. Balanced accuracy for rhythm classification ranged from 38.6% to 55.8%, but sensitivity for atrial fibrillation among generalist models was ≤11.1%, detecting either none or only 1 of the 9 cases. Detection of first-degree AV block (sensitivity 0%‐22%; 0/9 to 2/9) and QTc prolongation (sensitivity 0%‐45.5%; 0/22 to 10/22) was poor. Intraventricular block was identified with up to 67.8% balanced accuracy, but correct subtype assignment was ≤44% (≤11/25). ST-segment deviation sensitivity was <25% for all generalist models (highest 3/14). Agreement with expert interpretation was low, with Cohen κ indicating poor-to-fair concordance (κ≤0.39). Specialized models achieved overall balanced accuracy of 56.5% (ECG-Instruct-Llama-3.2-11B-Vision) and 64.4% (PULSE-7B), with PULSE-7B showing higher task-specific balanced accuracy in rhythm classification and ectopic beats detection (up to 86.3% and 89.2%, respectively). Conclusions: VE-LLMs showed moderate overall performance but mostly low sensitivity and limited agreement with expert ECG interpretation. Current performance remains inconsistent across models and diagnostic categories and is insufficient to support clinical deployment.
- Open Access
- 31 October 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Performance of Vision-Enabled Large Language Models in ECG Interpretation: Exploratory Evaluation (Preprint)
BACKGROUND Vision-enabled large language models (VE-LLMs) have the potential to provide flexible and explainable medical image interpretation. However, their real-world performance on clinical data such as 12-lead electrocardiograms (ECGs) has not been systematically assessed. OBJECTIVE This study aimed to evaluate the diagnostic accuracy and reliability of state-of-the-art VE-LLMs in interpreting real-world ECG images. METHODS We tested eight VE-LLMs (ChatGPT-5, ChatGPT-4, Gemini 2.5 Pro, Copilot, Grok-4, Perplexity, Claude Sonnet-4, and Claude Opus-4.1) using 70 de-identified ECG images. A standardized prompt requested nine determinations: rhythm, first-degree atrioventricular (AV) block, intraventricular conduction block and pattern, corrected QT (QTc) prolongation, premature atrial and ventricular contractions, ischemic ST-segment deviation, and axis deviation. An expert consensus served as the reference standard. Model outputs were evaluated using overall and per-class diagnostic metrics. RESULTS Overall accuracy across models varied significantly from 68.1% to 78.3% (429/630 to 493/630, Cochran’s Q, P<.001). ChatGPT-5 achieved the highest accuracy (78.3%) but had the slowest response time (median 276 seconds), whereas Perplexity and Copilot responded within a median of 2 and 3 seconds, respectively. Rhythm classification reached 72.9%–82.9% accuracy (51/70 to 58/70), but sensitivity for atrial fibrillation was ≤22% (≤2/9). Detection of first-degree AV block was poor (sensitivity 0%–33%; 0/9 to 3/9), and QTc prolongation was also poor (sensitivity 0%–45.5%; 0/22 to 10/22). Intraventricular block was identified with up to 70% accuracy (49/70), but correct subtype assignment was ≤44% (≤11/25). ST-segment deviation sensitivity was <25% for all models (highest 3/14). Agreement with expert interpretation was low, with Cohen’s kappa (κ) indicating poor-to-fair concordance (κ≤.37). CONCLUSIONS VE-LLMs showed moderate overall accuracy but low sensitivity and limited agreement with expert ECG interpretation. Current performance is inconsistent and insufficient for clinical deployment. Future development should focus on domain-specific training and hybrid approaches combining LLM reasoning with established ECG algorithms before use in patient care.
- 31 October 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessPerformance of Vision-Enabled Large Language Models in ECG Interpretation: Exploratory Evaluation (Preprint)
BACKGROUND Vision-enabled large language models (VE-LLMs) have the potential to provide flexible and explainable medical image interpretation. However, their real-world performance on clinical data such as 12-lead electrocardiograms (ECGs) has not been systematically assessed. OBJECTIVE This study aimed to evaluate the diagnostic accuracy and reliability of state-of-the-art VE-LLMs in interpreting real-world ECG images. METHODS We tested eight VE-LLMs (ChatGPT-5, ChatGPT-4, Gemini 2.5 Pro, Copilot, Grok-4, Perplexity, Claude Sonnet-4, and Claude Opus-4.1) using 70 de-identified ECG images. A standardized prompt requested nine determinations: rhythm, first-degree atrioventricular (AV) block, intraventricular conduction block and pattern, corrected QT (QTc) prolongation, premature atrial and ventricular contractions, ischemic ST-segment deviation, and axis deviation. An expert consensus served as the reference standard. Model outputs were evaluated using overall and per-class diagnostic metrics. RESULTS Overall accuracy across models varied significantly from 68.1% to 78.3% (429/630 to 493/630, Cochran’s Q, P<.001). ChatGPT-5 achieved the highest accuracy (78.3%) but had the slowest response time (median 276 seconds), whereas Perplexity and Copilot responded within a median of 2 and 3 seconds, respectively. Rhythm classification reached 72.9%–82.9% accuracy (51/70 to 58/70), but sensitivity for atrial fibrillation was ≤22% (≤2/9). Detection of first-degree AV block was poor (sensitivity 0%–33%; 0/9 to 3/9), and QTc prolongation was also poor (sensitivity 0%–45.5%; 0/22 to 10/22). Intraventricular block was identified with up to 70% accuracy (49/70), but correct subtype assignment was ≤44% (≤11/25). ST-segment deviation sensitivity was <25% for all models (highest 3/14). Agreement with expert interpretation was low, with Cohen’s kappa (κ) indicating poor-to-fair concordance (κ≤.37). CONCLUSIONS VE-LLMs showed moderate overall accuracy but low sensitivity and limited agreement with expert ECG interpretation. Current performance is inconsistent and insufficient for clinical deployment. Future development should focus on domain-specific training and hybrid approaches combining LLM reasoning with established ECG algorithms before use in patient care.
- Open Access
- 8 July 2025
- Published by Springer Nature in Heart and Vessels
- Vol. 40 (12) , 1116-1124
Comparison between contrast-guided and pressure-guided ablation using the novel pressure visualization tool for cryoballoon pulmonary vein isolation
During cryoballon pulmonary vein isolation (PVI) complete occlusion of the pulmonary vein ostia during the freeze cycles is mandatory. Typically, PV occlusion is assessed by contrast injection under fluoroscopy. Using an update for the Cryo Console it is possible to directly visualize occlusion pressure as an indicator of complete PV occlusion during cryoballoon procedures. In this study, we compared PV pressure monitoring during cryoballoon PVI to a conventional approach regarding procedural outcomes. We retrospectively analysed the procedural data of 50 patients (25 patients with pressure-guided PVI and 25 patients with contrast-guided PVI) treated with cryoballoon PVI in our centre. Complete PV occlusion in the pressure-guided group was defined as an abrupt change in the pressure waveform with a loss of the a-wave after advancing the cryoballoon to the PV ostium. We observed comparable results regarding procedural time, left atrial dwell time or fluoroscopy time when comparing the pressure guided to our conventional approach. Moreover, there were no differences regarding acute procedural effectivity or freeze cycle characteristics. As expected, a significant reduction of contrast use was achieved in the pressure measurement group (10.4 vs. 25.5 ml, p < 0.0001). Monitoring complete PV occlusion by visualizing the occlusion pressure is feasible. Acute procedural outcome was comparable to our standard approach using contrast injection to verify complete PV occlusion. Most importantly, a significant reduction in contrast use could be achieved which has to be confirmed in larger patient cohorts.
- 8 July 2025
- Published by Springer Nature in Heart and Vessels
- Vol. 40 (12) , 1116-1124
Open AccessComparison between contrast-guided and pressure-guided ablation using the novel pressure visualization tool for cryoballoon pulmonary vein isolation
During cryoballon pulmonary vein isolation (PVI) complete occlusion of the pulmonary vein ostia during the freeze cycles is mandatory. Typically, PV occlusion is assessed by contrast injection under fluoroscopy. Using an update for the Cryo Console it is possible to directly visualize occlusion pressure as an indicator of complete PV occlusion during cryoballoon procedures. In this study, we compared PV pressure monitoring during cryoballoon PVI to a conventional approach regarding procedural outcomes. We retrospectively analysed the procedural data of 50 patients (25 patients with pressure-guided PVI and 25 patients with contrast-guided PVI) treated with cryoballoon PVI in our centre. Complete PV occlusion in the pressure-guided group was defined as an abrupt change in the pressure waveform with a loss of the a-wave after advancing the cryoballoon to the PV ostium. We observed comparable results regarding procedural time, left atrial dwell time or fluoroscopy time when comparing the pressure guided to our conventional approach. Moreover, there were no differences regarding acute procedural effectivity or freeze cycle characteristics. As expected, a significant reduction of contrast use was achieved in the pressure measurement group (10.4 vs. 25.5 ml, p < 0.0001). Monitoring complete PV occlusion by visualizing the occlusion pressure is feasible. Acute procedural outcome was comparable to our standard approach using contrast injection to verify complete PV occlusion. Most importantly, a significant reduction in contrast use could be achieved which has to be confirmed in larger patient cohorts.
- Open Access
- 28 March 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 9 (4)
Smartwatch-enabled early detection and treatment of cardiomyopathy induced by premature atrial contractions: a case report
Background: Arrhythmia-induced cardiomyopathy (AiCM) is an increasingly recognized cause of heart failure. Atrial fibrillation and premature ventricular contractions are common causes of AiCM. Further, the use of wearable technology in arrhythmia detection is increasing steadily. In this case, we report on a patient suffering from AiCM as a result of frequent premature atrial contractions (PACs) detected by a wearable device. Case summary: A 34-year-old male, with no prior medical history, presented after his smartwatch detected frequent ‘heart arrhythmias.’ An initial electrocardiogram showed sinus rhythm with frequent PACs. Further evaluation revealed left ventricular dysfunction [left ventricular ejection fraction (LVEF) 35%]. Non-invasive tests ruled out coronary artery disease. Although the patient was initially asymptomatic, his condition worsened with a decline in LVEF to 15% despite optimal medical therapy. High-resolution 3D mapping identified the ectopic focus in the left inferior pulmonary vein, and radiofrequency ablation successfully eliminated the PACs. At the six-month follow-up, the patient was symptom-free with a recovered LVEF of 50%. Discussion: This case highlights the potential for frequent PACs to induce AiCM. Although PACs are typically considered benign, in this case, the high PAC burden led to significant left ventricular dysfunction. The successful resolution of the patient’s symptoms and the improvement in heart function after radiofrequency ablation demonstrate the reversibility of AiCM caused by PACs if treated early. Importantly, this case underscores the emerging role of wearable technologies, like smartwatches, in the early detection of arrhythmias, enabling timely intervention to prevent the progression of heart failure.
- 28 March 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 9 (4)
Open AccessSmartwatch-enabled early detection and treatment of cardiomyopathy induced by premature atrial contractions: a case report
Background: Arrhythmia-induced cardiomyopathy (AiCM) is an increasingly recognized cause of heart failure. Atrial fibrillation and premature ventricular contractions are common causes of AiCM. Further, the use of wearable technology in arrhythmia detection is increasing steadily. In this case, we report on a patient suffering from AiCM as a result of frequent premature atrial contractions (PACs) detected by a wearable device. Case summary: A 34-year-old male, with no prior medical history, presented after his smartwatch detected frequent ‘heart arrhythmias.’ An initial electrocardiogram showed sinus rhythm with frequent PACs. Further evaluation revealed left ventricular dysfunction [left ventricular ejection fraction (LVEF) 35%]. Non-invasive tests ruled out coronary artery disease. Although the patient was initially asymptomatic, his condition worsened with a decline in LVEF to 15% despite optimal medical therapy. High-resolution 3D mapping identified the ectopic focus in the left inferior pulmonary vein, and radiofrequency ablation successfully eliminated the PACs. At the six-month follow-up, the patient was symptom-free with a recovered LVEF of 50%. Discussion: This case highlights the potential for frequent PACs to induce AiCM. Although PACs are typically considered benign, in this case, the high PAC burden led to significant left ventricular dysfunction. The successful resolution of the patient’s symptoms and the improvement in heart function after radiofrequency ablation demonstrate the reversibility of AiCM caused by PACs if treated early. Importantly, this case underscores the emerging role of wearable technologies, like smartwatches, in the early detection of arrhythmias, enabling timely intervention to prevent the progression of heart failure.
- 15 July 2024
- Published by Springer Nature in Die Innere Medizin
- Vol. 65 (8) , 755-761
Vorhofflimmern und Herzinsuffizienz
- 15 July 2024
- Published by Springer Nature in Die Innere Medizin
- Vol. 65 (8) , 755-761
Vorhofflimmern und Herzinsuffizienz
- Open Access
- 13 July 2024
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 67 (9) , 2067-2075
Next-generation atrial fibrillation ablation: clinical performance of pulsed-field ablation and very high-power short-duration radiofrequency
Introduction: Pulsed-field energy (PFA) and very high-power short-duration radiofrequency (vHPSD-RF) are two novel ablation methods for pulmonary vein isolation (PVI). Both PFA and vHPSD-RF show promise for improving efficacy, safety, and reducing procedure durations. However, direct comparisons between these two techniques are scarce. Methods and results: Retrospective analysis of 82 patients with symptomatic AF. Of these, 52 patients received PFA and 30 received vHPSD-RF (90 W, 4 s) as index procedure. At the 6-month follow-up, AF recurrence occurred in 4 patients following PFA and 5 patients following vHPSD-RF (p-value = 0.138). Significant improvements in the EHRA and NYHA stages were evident in both PFA (p < 0.001 and p = 0.047, respectively) and vHPSD-RF groups (p = 0.007 and p = 0.012, respectively). The total procedure duration and the left atrial dwell time were significantly shorter in the PFA group (64 ± 19 min vs. 99 ± 32 min, p < 0.001 and 41 ± 12 min vs. 62 ± 29 min, p < 0.001, respectively). The fluoroscopy time and dose area product were significantly higher in PFA (14 ± 6 vs. 9 ± 5 min, p < 0.001 and 14 ± 9 vs. 11 ± 9 Gy cm2, p = 0.046, respectively). One patient in the vHPSD-RF group suffered a stroke, not directly linked to the procedure (0 vs. 1 major complication, p = 0.366). Conclusion: Based on this retrospective single-center study, PFA and vHPSD-RF were associated with similar effectiveness and safety profiles. PFA was linked to shorter procedure times and higher radiation exposure compared to vHPSD-RF. Graphical
- 13 July 2024
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 67 (9) , 2067-2075
Open AccessNext-generation atrial fibrillation ablation: clinical performance of pulsed-field ablation and very high-power short-duration radiofrequency
Introduction: Pulsed-field energy (PFA) and very high-power short-duration radiofrequency (vHPSD-RF) are two novel ablation methods for pulmonary vein isolation (PVI). Both PFA and vHPSD-RF show promise for improving efficacy, safety, and reducing procedure durations. However, direct comparisons between these two techniques are scarce. Methods and results: Retrospective analysis of 82 patients with symptomatic AF. Of these, 52 patients received PFA and 30 received vHPSD-RF (90 W, 4 s) as index procedure. At the 6-month follow-up, AF recurrence occurred in 4 patients following PFA and 5 patients following vHPSD-RF (p-value = 0.138). Significant improvements in the EHRA and NYHA stages were evident in both PFA (p < 0.001 and p = 0.047, respectively) and vHPSD-RF groups (p = 0.007 and p = 0.012, respectively). The total procedure duration and the left atrial dwell time were significantly shorter in the PFA group (64 ± 19 min vs. 99 ± 32 min, p < 0.001 and 41 ± 12 min vs. 62 ± 29 min, p < 0.001, respectively). The fluoroscopy time and dose area product were significantly higher in PFA (14 ± 6 vs. 9 ± 5 min, p < 0.001 and 14 ± 9 vs. 11 ± 9 Gy cm2, p = 0.046, respectively). One patient in the vHPSD-RF group suffered a stroke, not directly linked to the procedure (0 vs. 1 major complication, p = 0.366). Conclusion: Based on this retrospective single-center study, PFA and vHPSD-RF were associated with similar effectiveness and safety profiles. PFA was linked to shorter procedure times and higher radiation exposure compared to vHPSD-RF. Graphical
- Top Cited PapersOpen Access
- 8 July 2024
- Published by Springer Nature in Nature Medicine
- Vol. 30 (7) , 2020-2029
Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study
Pulsed field ablation (PFA) is an emerging technology for the treatment of atrial fibrillation (AF), for which pre-clinical and early-stage clinical data are suggestive of some degree of preferentiality to myocardial tissue ablation without damage to adjacent structures. Here in the MANIFEST-17K study we assessed the safety of PFA by studying the post-approval use of this treatment modality. Of the 116 centers performing post-approval PFA with a pentaspline catheter, data were received from 106 centers (91.4% participation) regarding 17,642 patients undergoing PFA (mean age 64, 34.7% female, 57.8% paroxysmal AF and 35.2% persistent AF). No esophageal complications, pulmonary vein stenosis or persistent phrenic palsy was reported (transient palsy was reported in 0.06% of patients; 11 of 17,642). Major complications, reported for ~1% of patients (173 of 17,642), were pericardial tamponade (0.36%; 63 of 17,642) and vascular events (0.30%; 53 of 17,642). Stroke was rare (0.12%; 22 of 17,642) and death was even rarer (0.03%; 5 of 17,642). Unexpected complications of PFA were coronary arterial spasm in 0.14% of patients (25 of 17,642) and hemolysis-related acute renal failure necessitating hemodialysis in 0.03% of patients (5 of 17,642). Taken together, these data indicate that PFA demonstrates a favorable safety profile by avoiding much of the collateral damage seen with conventional thermal ablation. PFA has the potential to be transformative for the management of patients with AF.
- 8 July 2024
- Published by Springer Nature in Nature Medicine
- Vol. 30 (7) , 2020-2029
Top Cited PapersOpen AccessSafety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study
Pulsed field ablation (PFA) is an emerging technology for the treatment of atrial fibrillation (AF), for which pre-clinical and early-stage clinical data are suggestive of some degree of preferentiality to myocardial tissue ablation without damage to adjacent structures. Here in the MANIFEST-17K study we assessed the safety of PFA by studying the post-approval use of this treatment modality. Of the 116 centers performing post-approval PFA with a pentaspline catheter, data were received from 106 centers (91.4% participation) regarding 17,642 patients undergoing PFA (mean age 64, 34.7% female, 57.8% paroxysmal AF and 35.2% persistent AF). No esophageal complications, pulmonary vein stenosis or persistent phrenic palsy was reported (transient palsy was reported in 0.06% of patients; 11 of 17,642). Major complications, reported for ~1% of patients (173 of 17,642), were pericardial tamponade (0.36%; 63 of 17,642) and vascular events (0.30%; 53 of 17,642). Stroke was rare (0.12%; 22 of 17,642) and death was even rarer (0.03%; 5 of 17,642). Unexpected complications of PFA were coronary arterial spasm in 0.14% of patients (25 of 17,642) and hemolysis-related acute renal failure necessitating hemodialysis in 0.03% of patients (5 of 17,642). Taken together, these data indicate that PFA demonstrates a favorable safety profile by avoiding much of the collateral damage seen with conventional thermal ablation. PFA has the potential to be transformative for the management of patients with AF.
- 1 June 2024
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 17 (6) , e012698
Pulsed Field Ablation of Atrial Fibrillation and Atrial Tachycardia in Adult Patients With Congenital Heart Disease
- 1 June 2024
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 17 (6) , e012698
Pulsed Field Ablation of Atrial Fibrillation and Atrial Tachycardia in Adult Patients With Congenital Heart Disease
- Open Access
- 1 March 2024
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 26 (3)
Atrial fibrillation ablation workflow optimization facilitated by high-power short-duration ablation and high-resolution mapping
Pulmonary vein isolation (PVI) for catheter ablation of atrial fibrillation (AF) is a time-demanding procedure. High-power short-duration (HPSD) ablation protocols and high-density mapping catheters have recently been introduced to clinical practice. We investigated the impact of high-density mapping and HPSD ablation protocols on procedural timing, efficacy, and safety by comparing different standardized set-ups. Three electrophysiology (EP) laboratory set-ups were analysed: (i) circular catheter for mapping and HPSD ablation with 30/35 W guided by an ablation index (AI); (ii) pentaspline catheter for mapping an HPSD ablation with 50 W guided by an AI; and (iii) pentaspline catheter for mapping and HPSD ablation with 90 W over 4 s using a novel ablation catheter. All patients underwent PVI without additional left atrial ablation strategies. Procedural data and operating intervals in the EP laboratory were systematically analysed. Three hundred seven patients were analysed (30/35 W AI: n = 102, 50 W AI: n = 102, 90 W/4 s: n = 103). Skin-to-skin times [105.3 ± 22.7 (30/35 W AI) vs. 81.4 ± 21.3 (50 W AI) vs. 69.5 ± 12.2 (90 W/4 s) min, P ≤ 0.001] and total laboratory times (132.8 ± 42.1 vs. 107.4 ± 25.7 vs. 95.2 ± 14.0 min, P < 0.001) significantly differed among the study groups. Laboratory interval analysis revealed significant shortening of mapping and ablation times. Arrhythmia-free survival after 12 months was not different among the study groups (log-rank P = 0.96). The integration of high-density mapping and HPSD protocols into an institutional AF ablation process resulted in reduced procedure times without compromising safety or efficacy.
- 1 March 2024
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 26 (3)
Open AccessAtrial fibrillation ablation workflow optimization facilitated by high-power short-duration ablation and high-resolution mapping
Pulmonary vein isolation (PVI) for catheter ablation of atrial fibrillation (AF) is a time-demanding procedure. High-power short-duration (HPSD) ablation protocols and high-density mapping catheters have recently been introduced to clinical practice. We investigated the impact of high-density mapping and HPSD ablation protocols on procedural timing, efficacy, and safety by comparing different standardized set-ups. Three electrophysiology (EP) laboratory set-ups were analysed: (i) circular catheter for mapping and HPSD ablation with 30/35 W guided by an ablation index (AI); (ii) pentaspline catheter for mapping an HPSD ablation with 50 W guided by an AI; and (iii) pentaspline catheter for mapping and HPSD ablation with 90 W over 4 s using a novel ablation catheter. All patients underwent PVI without additional left atrial ablation strategies. Procedural data and operating intervals in the EP laboratory were systematically analysed. Three hundred seven patients were analysed (30/35 W AI: n = 102, 50 W AI: n = 102, 90 W/4 s: n = 103). Skin-to-skin times [105.3 ± 22.7 (30/35 W AI) vs. 81.4 ± 21.3 (50 W AI) vs. 69.5 ± 12.2 (90 W/4 s) min, P ≤ 0.001] and total laboratory times (132.8 ± 42.1 vs. 107.4 ± 25.7 vs. 95.2 ± 14.0 min, P < 0.001) significantly differed among the study groups. Laboratory interval analysis revealed significant shortening of mapping and ablation times. Arrhythmia-free survival after 12 months was not different among the study groups (log-rank P = 0.96). The integration of high-density mapping and HPSD protocols into an institutional AF ablation process resulted in reduced procedure times without compromising safety or efficacy.